Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported; Fiscal 2016 Revenue of $910 Million, Constant Currency Revenue Growth o

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. NKE
10. PRIM

Go back to Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported; Fiscal 2016 Revenue of $910 Million, Constant Currency Revenue Growth o

Haemonetics (HAE) Misses Q4 EPS by 9c

May 2, 2016 6:36 AM EDT

Haemonetics (NYSE: HAE) reported Q4 EPS of $0.37, $0.09 worse than the analyst estimate of $0.46. Revenue for the quarter came in at $243.2 million versus the consensus estimate of $245.08 million.

For earnings history and earnings-related data on Haemonetics (HAE) click here.

... More